Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/13/2025

Cough Management in Hypertensive Patients

Medication Recommendations

  • Oral decongestants should be used with extreme caution or avoided entirely in patients with hypertension, as they can elevate blood pressure, according to the Journal of Allergy and Clinical Immunology 1
  • Most OTC combination cold medications are not recommended, with the exception of older antihistamine-decongestant combinations, though even these carry hypertension concerns, as stated by Chest and American Family Physician 2, 3, 4
  • Codeine (30 mg three times daily) or dextromethorphan (30 mg as needed) are recommended for short-term symptomatic relief in chronic bronchitis (Grade B recommendation), according to Chest 2, 3
  • Central cough suppressants like codeine and dextromethorphan have limited efficacy for URI-related cough and are not recommended (Grade D recommendation), as reported by Chest 2, 3
  • First-generation antihistamines (like diphenhydramine) combined with decongestants are recommended for acute cough from the common cold, but the decongestant component poses hypertension risk, according to American Family Physician 4
  • Ipratropium bromide is the only inhaled anticholinergic specifically recommended for cough suppression (Grade A recommendation for URI/chronic bronchitis), as stated by Chest 2, 3, 5

ACE Inhibitor-Induced Cough

  • If the hypertensive patient is taking an ACE inhibitor, this is the most common medication-related cause of persistent dry cough, occurring in 5-35% of patients, according to Praxis Medical Insights 6, 7
  • Discontinuing the ACE inhibitor is the only uniformly effective treatment, with cough resolution expected within 1-4 weeks, as reported by Praxis Medical Insights 6, 7
  • The American College of Cardiology strongly recommends (Grade A) switching to an angiotensin receptor blocker (ARB) when ACE inhibitor-induced cough occurs, according to Praxis Medical Insights 6
  • Losartan 25 mg once daily is the most studied ARB for patients with ACE inhibitor-induced cough, with titration to 50 mg if needed for blood pressure control, as stated by Praxis Medical Insights 6

Practical Guidelines

  • The American College of Cardiology recommends determining if the patient is on an ACE inhibitor and switching to an ARB if necessary, as reported by Praxis Medical Insights 6, 7
  • For symptomatic cough relief while maintaining blood pressure control, the first-line treatment is benzonatate, followed by ipratropium bromide inhaler, and then codeine or dextromethorphan, according to Chest and Praxis Medical Insights 2, 5, 6, 7
  • Oral decongestants and most OTC combination products should be avoided entirely, as stated by Journal of Allergy and Clinical Immunology, Chest, and American Family Physician 1, 2, 3, 4

REFERENCES